The fully linked HTML version of this article has now been published.
JCS ePress
online publication date 9 Nov 2004
doi: 10.1242/jcs.01418
Research Article
Requirements for the destruction of human Aurora-A
Richard Crane,
Angela Kloepfer,
and
Joan V. Ruderman*
* Author for correspondence (e-mail: ruderman{at}hms.harvard.edu)
The mitotic kinase Aurora A (Aur-A) is overexpressed in a high proportion of human tumors, often in the absence of gene amplification. In somatic cells, Aur-A protein levels fall following mitosis or upon overexpression of Cdh1, an activator of the ubiquitin ligase APC/C. Thus, mutations that reduce or block the rate of Aur-A destruction might also be expected to contribute to its oncogenic potential. Previous work had defined two short sequences of Xenopus Aur-A that are required for its Cdh1-inducible destruction in extracts of Xenopus eggs, an N-terminal A box and a C-terminal D box, and a serine residue within the A box whose phosphorylation might inhibit destruction. Here, we show that these same sequences are required for the destruction of human Aur-A during mitotic exit and G1 in the somatic cell cycle. Expression of a dominant negative Cdh1 protein leads to accumulation of Aur-A, further indicating that the Cdh1-activated form of the APC/C is responsible for destruction of Aur-A during the somatic cell cycle in vivo. During the course of this work, we found some previously unsuspected problems in commonly used in vitro destruction assays, which can result in misleading results. Potentially confounding factors include: (i) the presence of D-box- and A-box-dependent destruction-promoting activities in the reticulocyte in vitro translation mix that is used to produce radiolabeled substrates for destruction assays; and (ii) the ability of green-fluorescent-protein tags to reduce the destruction rate of Aur-A substantially. These findings have direct relevance for studies of Aur-A destruction itself, and for broader approaches that use in vitro translation products in screens for additional APC/C targets.
This article has been cited by other articles:
|
|
|
|
 
C. Man, J. Rosa, Y. L. Yip, A. L.-M. Cheung, Y. L. Kwong, S. J. Doxsey, and S. W. Tsao
Id1 Overexpression Induces Tetraploidization and Multiple Abnormal Mitotic Phenotypes by Modulating Aurora A
Mol. Biol. Cell,
June 1, 2008;
19(6):
2389 - 2401.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Fu, M. Bian, Q. Jiang, and C. Zhang
Roles of Aurora Kinases in Mitosis and Tumorigenesis
Mol. Cancer Res.,
January 1, 2007;
5(1):
1 - 10.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. S. Udayakumar, M. Belakavadi, K.-H. Choi, P. K. Pandey, and J. D. Fondell
Regulation of Aurora-A Kinase Gene Expression via GABP Recruitment of TRAP220/MED1
J. Biol. Chem.,
May 26, 2006;
281(21):
14691 - 14699.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. S. Stanford and J. V. Ruderman
Changes in Regulatory Phosphorylation of Cdc25C Ser287 and Wee1 Ser549 during Normal Cell Cycle Progression and Checkpoint Arrests
Mol. Biol. Cell,
December 1, 2005;
16(12):
5749 - 5760.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Stewart and G. Fang
Destruction Box-Dependent Degradation of Aurora B Is Mediated by the Anaphase-Promoting Complex/Cyclosome and Cdh1
Cancer Res.,
October 1, 2005;
65(19):
8730 - 8735.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Fukuda, Y. Mishina, M. P. Walker, and R. P. DiAugustine
Conditional Transgenic System for Mouse Aurora A Kinase: Degradation by the Ubiquitin Proteasome Pathway Controls the Level of the Transgenic Protein
Mol. Cell. Biol.,
June 15, 2005;
25(12):
5270 - 5281.
[Abstract]
[Full Text]
[PDF]
|
|
|
© The Company of Biologists Ltd 2004
